Condition
Acute DVT of Lower Extremity
Total Trials
5
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 47/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
100%
2 of 2 completed with results
Key Signals
2 with results67% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
Early P 1 (1)
Trial Status
Completed2
Not Yet Recruiting1
Terminated1
Unknown1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07335341Not Yet Recruiting
Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System
NCT06446024Completed
Post Market Surveillance to Evaluate the Efficacy and Safety of the INDIGO Aspiration System in Japan
NCT03575364Completed
ClotTriever Outcomes (CLOUT) Registry
NCT06145269Early Phase 1UnknownPrimary
Recanalization Rate of Acute DVT
NCT03465735Not ApplicableTerminatedPrimary
Vascular Boot Warming Program After Acute Deep Vein Thrombosis (DVT) ± Pulmonary Embolism (PE)
Showing all 5 trials